Integrum, a leading provider of innovative solutions for bone anchored prosthetics, has today announced a contract with Johns Hopkins Hospital to offer an innovative surgical service to above-the-knee amputees in the U.S.
The prestigious Johns Hopkins Hospital has started an osseointegration based service lead by Orthopaedic Oncologist, Dr. Jonathan Forsberg, and Plastic Surgeon, Dr. Jamie Shores. The aim of the osseointegration program is to improve limb function and reducing pain and skin-related complications for patients in the United States and abroad.
Blake Pokress, Vice President of Integrum North America added," We’re delighted to be collaborating with the surgical team at Johns Hopkins. It’s an exciting time for osseointegration in the United States and Johns Hopkins has positioned itself to be one of the leaders in the care of people affected by limb loss."
The information in this press release is information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out below, at 16:00 CET on Oct 21, 2019.
Integrum AB is listed on Nasdaq First North in Stockholm. Erik Penser is the Company’s Certified Adviser
For further information contact
María López, CEO. Mobile: +46 708 46 10 69, Email: email@example.com
Blake Pokress, VP North America. Mobile: 650-862-9302, Email: firstname.lastname@example.org
Erik Penser Bank AB, Certified Adviser can be reached at +46 8 463 8000 or email@example.com
Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRA implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from 500 surgeries in 14 countries, Integrum has today a leading position in bone anchored protheses. The company is publicly listed at Nasdaq First North Market.
Se fullständiga pressmeddelande och andra nyheter från detta bolag hos Cision News